SEC Comment Letter for GOLDENWELL BIOTECH, INC. (GWLL) (CIK 0001800373) (GWLL) — Sep 22, 2022
GOLDENWELL BIOTECH, INC. (GWLL) (CIK 0001800373)
Date: Sept. 22, 2022 · CIK: 0001800373 · Accession: 0000000000-22-010454
AI Filing Summary & Sentiment
File numbers found in text: 000-56275
Letter
United States securities and exchange commission logo September 22, 2022 Shuang Liu Chief Executive Officer, President, and Director Goldenwell Biotech, Inc. 2071 Midway Drive Twinsburg, OH 44087 Re:Goldenwell Biotech, Inc. Form 10-K for the Fiscal Year ended December 31, 2021 Filed April 1, 2022 File No. 000-56275 Dear Mr. Liu: We issued comments to you on the above captioned filing on August 3, 2022. As of the date of this letter, these comments remain outstanding and unresolved. We expect you to provide a complete, substantive response to these comments by October 6, 2022. If you do not respond, we will, consistent with our obligations under the federal securities laws, decide how we will seek to resolve material outstanding comments and complete our review of your filing and your disclosure. Among other things, we may decide to release publicly, through the agency's EDGAR system, all correspondence, including this letter, relating to the review of your filings, consistent with the staff's decision to publicly release comment and response letters relating to disclosure filings it has reviewed. You may contact Joseph Klinko at (202) 551-3824 or Lily Dang at (202) 551-3867 with any questions regarding this letter or the comments in the letter referenced above. Sincerely, Division of Corporation Finance Office of Energy & Transportation
Show Raw Text
United States securities and exchange commission logo
September 22, 2022
Shuang Liu
Chief Executive Officer, President, and Director
Goldenwell Biotech, Inc.
2071 Midway Drive
Twinsburg, OH 44087
Re:Goldenwell Biotech, Inc.
Form 10-K for the Fiscal Year ended December 31, 2021
Filed April 1, 2022
File No. 000-56275
Dear Mr. Liu:
We issued comments to you on the above captioned filing on August 3, 2022. As of the
date of this letter, these comments remain outstanding and unresolved. We expect you to
provide a complete, substantive response to these comments by October 6, 2022.
If you do not respond, we will, consistent with our obligations under the federal securities
laws, decide how we will seek to resolve material outstanding comments and complete our
review of your filing and your disclosure. Among other things, we may decide to release
publicly, through the agency's EDGAR system, all correspondence, including this letter, relating
to the review of your filings, consistent with the staff's decision to publicly release comment and
response letters relating to disclosure filings it has reviewed.
You may contact Joseph Klinko at (202) 551-3824 or Lily Dang at (202) 551-3867 with
any questions regarding this letter or the comments in the letter referenced above.
Sincerely,
Division of Corporation Finance
Office of Energy & Transportation